Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROFLUMILAST vs ROLAPITANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROFLUMILAST vs ROLAPITANT: Safety Overview

Metric ROFLUMILAST ROLAPITANT
Total FAERS Reports 2,700 873
Deaths Reported 645 252
Death Rate 23.9% 28.9%
Hospitalizations 625 155
Average Patient Age 68.8 yrs 61.4 yrs
% Female Patients 56.3% 57.5%
FDA Approval Date Apr 17, 2023 Oct 25, 2017
Manufacturer Aurobindo Pharma Limited TerSera Therapeutics LLC
Route ORAL ORAL
Marketing Status Prescription Prescription